|
|
||||
|
|
||||
|
||||
Epidemiology and Cancer Control |
Divisions of Medical Oncology and Hematology (J.B., N.B.), Radiation Oncology (R.G.M.), and Pathology (M.S.L., M.S.), Toronto - Sunnybrook Regional Cancer Centre, Sunnybrook and Women's College Health Science Centre, University of Toronto, Toronto, Ontario, Canada M4N 3M5
1 Address correspondence and reprint requests to Robert G. MacKenzie, Division of Radiation Oncology, Toronto-Sunnybrook Regional Cancer Centre, 2075 Bayview Ave., Toronto, Ontario, Canada, M4N 3M5.
Abstract
Primary Hodgkin's disease limited to the CNS is exceedingly rare. Little is known regarding etiologic risk factors, optimal management, and prognosis. A case of Hodgkin's disease confined to the CNS, with cerebrospinal `uid negative for cytology, is described in an immunocompetent patient previously treated for hyperthyroidism with 131I. The patient underwent craniotomy, with resection of two lesions in close proximity within the parenchyma of the temporoparietal lobe. Histopathology revealed classic nodular sclerosing Hodgkin's disease, without evidence of Epstein-Barr viral infection. Treatment included radiation to the whole brain with a boost to the tumor bed. The patient made a full neurologic recovery and remains free of disease recurrence 21 months after treatment. A literature review has identified only 9 additional cases. Seven of 8 evaluable patients remain alive and free of recurrence with a median follow-up of 13 months. The risk factors for this presentation remain undefined. Although follow-up is short, radiotherapy alone appears to provide excellent disease-free survival. Chemotherapy may be reserved for patients with positive cerebrospinal `uid, extracranial disease, or subsequent relapse.
References
Abrahamsen, A.F., Hannisdal, E., Nome, O., Holte, H., Hager, B.,
Langholm, R., and Kvaloy, S. (1996) Clinical stage I and II
Hodgkin's disease: Long-term results of therapy without laparotomy: Experience
at one institution. Ann. Oncol.
7, 145-150.
Algers, G., Boquist, L., Fodstad, H., Liliequist, B., and Singounas, E. (1981) Hodgkin's disease primarily localized to the brain: Case report. Acta Neurochir. 59,231 -237.[CrossRef]
Ashby, M.A., Barber, P.C., Holmes, A.E., Freer, C.E., and Collins, R.D. (1988) Primary intracranial Hodgkin's disease: A case report and discussion. Am. J. Surg. Pathol. 12,294 -299.[Web of Science][Medline]
Bender, B.L., and Mayernik, D.G. (1986) Hodgkin's disease presenting with isolated craniospinal involvement. Cancer 58,1745 -1748.[CrossRef][Web of Science][Medline]
Bertelsen, K. (1970) Primary cerebral reticulosarcoma. Acta. Pathol. Microbiol. Scand. [A] 78,209 -214.[Medline]
Burstein, S.D., Kernohan, J.W., and Uihlein, A. (1963) Neoplasms of the reticuloendothelial system of the brain. Cancer 16,289 -305.[CrossRef][Web of Science][Medline]
Carbone, A., Tirelli, U., Vaccher, E., Volpe, R., Gloghini, A., Bertola, G., De Re, V., Rossi, C., Boiocchi, M., and Monfardini, S. (1991) A clinicopathologic study of lymphoid neoplasias associated with human immunodeficiency virus infection in Italy. Cancer 68,842 -852.[CrossRef][Web of Science][Medline]
Clark, W.C., Callihan, T., Schwartzberg, L., and Fontanesi, J. (1992) Primary intracranial Hodgkin's lymphoma without dural attachment: Case report. J. Neurosurg. 76,692 -695.[Web of Science][Medline]
Cuttner, J., Meyer, R., and Huang, Y.P. (1979) Intracerebral involvement in Hodgkin's disease: A report of 6 cases and review of the literature. Cancer 43,1497 -1506.[CrossRef][Web of Science][Medline]
De Vathaire, F., Schlumberger, M., Delisle, M.J., Francese, C., Challeton, C., de la Genardiere, E., Meunier, F., Parmentier, C., Hill, C., and Sancho-Garnier, H. (1997) Leukaemias and cancers following iodine-131 administration for thyroid cancer. Br. J. Cancer 75,734 -739.[Web of Science][Medline]
Deckert-Schluter, M., Marek, J., Setlik, M., Markova, J., Pakos, E., Fischer, R., and Wiestler, O.D. (1998) Primary manifestation of Hodgkin's disease in the central nervous system. Virchows Arch. 432,477 -481.[CrossRef][Web of Science][Medline]
Doorly, T.P., Farrell, M.A., and Phillips, J. (1987)
Primary intracerebral Hodgkin's lymphoma. J. Neurol. Neurosurg.
Psychiatry 50,1048
-1050.
Dujovny, M., McBride, D., and Segal, R. (1980) Intracranial manifestations of Hodgkin's disease. Surg. Neurol. 13,258 -265.[Web of Science][Medline]
Franklyn, J.A., Maisonneuve, P., Sheppard, M.C., Betteridge, J.,
and Boyle, P. (1998) Mortality after the treatment of
hyperthyroidism with radioactive iodine. N. Engl. J.
Med. 338,712
-718.
Gatti, R.A., and Good, R.A. (1971) Occurrence of malignancy in immunodeficiency diseases: A literature review. Cancer 28,89 -98.[CrossRef][Web of Science][Medline]
Goldman, M.B., Maloof, F., Monson, R.R., Aschengrau, A., Cooper,
D.S., and Ridgway, E.C. (1988) Radioactive iodine therapy and
breast cancer: A follow-up study of hyperthyroid women. Am. J.
Epidemiol. 127,969
-980.
Gospodarowicz, M.K., Sutcliffe, S.B., Bergsagel, D.E., and Chua, T. (1992) Radiation therapy in clinical stage I and II Hodgkin's disease. Eur. J. Cancer 28A,1841 -1846.[CrossRef]
Hall, P., Boice, J.D., Jr., Berg, G., Bjelkengren, G., Ericsson, U.B., Hallquist, A., Lidberg, M., Lundell, G., Mattsson, A., Tennvall, J., Wiklund, K., and Holm, L.E. (1992) Leukaemia incidence after iodine-131 exposure. Lancet 340, 1-4.[Web of Science][Medline]
Henry, J.M., Heffner, R.R., Jr., Dillard, S.H., Earle, K.M., and Davis, R.L. (1974) Primary malignant lymphomas of the central nervous system. Cancer 34,1293 -1302.[CrossRef][Web of Science][Medline]
Hessol, N.A., Katz, M.H., Liu, J.Y., Buchbinder, S.P., Rubino, C.J., and Holmberg, S.D. (1992) Increased incidence of Hodgkin's disease in homosexual men with HIV infection. Ann. Int. Med. 117,309 -311.
Hoffman, D.A., McConahey, W.M., Diamond, E.L., and Kurland, L.T.
(1982) Mortality in women treated for hyperthyroidism.
Am. J. Epidemiol. 115,243
-254.
Holm, L.E., Hall, P., Wiklund, K., Lundell, G., Berg, G.,
Bjelkengren, G., Cederquist, E., Ericsson, U.B., Hallquist, A., Larsson, L.G.,
Lidberg, M., Lindberg, S., Tennvall, J., Wicklund, H., and Boice, J.D., Jr.
(1991) Cancer risk after iodine-131 therapy for hyperthyroidism.
J. Natl. Cancer Inst.
83,1072
-1077.
Klein, R., Mullges, W., Bendszus, M., Woydt, M., Kreipe, H., and Roggendorf, W. (1999) Primary intracerebral Hodgkin's disease: Report of a case with Epstein-Barr virus association and review of the literature. Am. J. Surg. Pathol. 23,477 -481.[CrossRef][Web of Science][Medline]
Laperriere, N.J., Cerezo, L., Milosevic, M.F., Wong, C.S., Patterson, B., and Panzarella, T. (1997) Primary lymphoma of brain: Results of management of a modern cohort with radiation therapy. Radiother. Oncol. 43,247 -252.[CrossRef][Web of Science][Medline]
Levine, A.M. (1998) Hodgkin's disease in the setting of human immunodeficiency virus infection. J. Natl. Cancer Inst. Monogr. 23,37 -42.
Nagashima, K., Mori, S., Yoshimasu, N., and Takahashi, K. (1980) Primary Hodgkin's disease of the falx cerebri. Acta. Neuropathol. (Berl.) 51,161 -163.[CrossRef][Medline]
Nelson, D.F., Martz, K.L., Bonner, H., Nelson, J.S., Newall, J., Kerman, H.D., Thomson, J.W., and Murray, K.J. (1992) Non-Hodgkin's lymphoma of the brain: Can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315. Int. J. Radiat. Oncol. Biol. Phys. 23,9 -17.[Web of Science][Medline]
Neuwelt, E.A., Goldman, D.L., Dahlborg, S.A., Crossen, J., Ramsey, F., Roman-Goldstein, S., Braziel, R., and Dana, B. (1991) Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function. J. Clin. Oncol. 9,1580 -1590.[Abstract]
Petruckevitch, A., Del Amo, J., Phillips, A.N., Stephenson, J.M.,
Johnson, A.M., and De Cock, K.M. (1999) Risk of cancer in
patients with HIV disease: London African HIV/AIDS Study Group.
Int. J. STD AIDS 10,38
-42.
Rabkin, C.S., Biggar, R.J., and Horm, J.W. (1991) Increasing incidence of cancers associated with the human immunodeficiency virus epidemic. Int. J. Cancer 47,692 -696.[Web of Science][Medline]
Ron, E., Doody, M.M., Becker, D.V., Brill, A.B., Curtis, R.E.,
Goldman, M.B., Harris, B.S., III, Hoffman, D.A., McConahey, W.M., Maxon, H.R.,
Preston-Martin, S., Warshauer, M.D., Wong, F.L., and Boice, J.D., Jr.
(1998) Cancer mortality following treatment for adult
hyperthyroidism: Cooperative Thyrotoxicosis Therapy Follow-up Study Group.
JAMA 280,347
-355.
Rubio, R. (1994) Hodgkin's disease associated with human immunodeficiency virus infection: A clinical study of 46 cases: Cooperative Study Group of Malignancies Associated with HIV Infection of Madrid. Cancer 73,2400 -2407.[CrossRef][Web of Science][Medline]
Sapozink, M.D., and Kaplan, H.S. (1983) Intracranial Hodgkin's disease: A report of 12 cases and review of the literature. Cancer 52,1301 -1307.[CrossRef][Web of Science][Medline]
Schoeppel, S., Hoppe, R., Abrams, D., Baer, D., Dorfman, R., Grant, K., Horning, S., Wilkinson, L., and Ziegler, J. (1986) Hodgkin's disease (HD) in homosexual men: The San Francisco Bay area experience. Proc. Am. Soc. Clin. Oncol. 5, 9 (abstract).
Schricker, J.L., Jr., and Smith, D.E. (1955) Primary intracerebral Hodgkin's disease. Cancer 8, 629-633.[CrossRef][Web of Science][Medline]
Serraino, D., Pezzoti, P., Dorrucci, M., Alliegro, M.B., Sinicco, A., and Rezza, G. (1997) Cancer incidence in a cohort of human immunodeficiency virus seroconverters: HIV Italian Seroconversion Study Group. Cancer 79,1004 -1008.[CrossRef][Web of Science][Medline]
Shimon, I., Kneller, A., and Olchovsky, D. (1995) Chronic myeloid leukaemia following 131I treatment for thyroid carcinoma: A report of two cases and review of the literature. Clin. Endocrinol. 43,651 -654.[Medline]
Sickler, G.K., Hanson, S.K., Hsu, S.M., and Papasozomenos, S.C. (1990) Primary intracerebral Hodgkin's disease: A case report. Clin. Neuropathol. 9,143 -147.[Web of Science][Medline]
Sparling, H.J., Jr., and Adams, R.D. (1946) Primary Hodgkin's sarcoma of the brain. Arch. Pathol. 42,338 -344.
Specht, L., Nordentoft, A.M., Cold, S., Clausen, N.T., and Nissen, N.I. (1988) Tumor burden as the most important prognostic factor in early stage Hodgkin's disease: Relations to other prognostic factors and implications for choice of treatment. Cancer 61,1719 -1727.[CrossRef][Web of Science][Medline]
Straus, D.J. (1997) Human immunodeficiency virus-associated lymphomas. Med. Clin. North Am. 81,495 -510.[CrossRef][Web of Science][Medline]
Tirelli, U., Errante, D., Vaccher, E., Repetto, L., Rizzardini, G., Spina, M., Gastaldi, R., Bertola, G., Serraino, D., Carbone, A., and Monfardini, S. (1992) Hodgkin's disease in 92 patients with HIV infection: The Italian experience. Ann. Oncol. 3 (Suppl. 4),69 -72.
Tirelli, U., Errante, D., Dolcetti, R., Gloghini, A., Serraino, D., Vaccher, E., Franceschi, S., Boiocchi, M., and Carbone, A. (1995) Hodgkin's disease and human immunodeficiency virus infection: clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and Tumors. J. Clin. Oncol. 13,1758 -1767.
Tubiana, M., Henry-Amar, M., Van der Werf-Messing, B., Henry, J., Abbatucci, J., Burgers, M., Hayat, M., Somers, R., Laugier, A., and Carde, P. (1985) A multivariate analysis of prognostic factors in early stage Hodgkin's disease. Int. J. Radiat. Oncol. Biol. Phys. 11,23 -30.[Web of Science][Medline]
Walgraeve, D., Verhoef, G., Stul, M., Cassiman, J.J., Mecucci, C., Van den Berghe, H., and Boogaerts, M. (1991) Chronic myelogenous leukemia after treatment with I131 for thyroid carcinoma: Report of a case and review of the literature. Cancer Genet. Cytogenet. 55,217 -224.[CrossRef][Web of Science][Medline]
Wood, N.L., and Coltman, C.A. (1973) Localized primary extranodal Hodgkin's disease. Ann. Int. Med. 78,113 -118.
Zimmerman, H.M. (1975) Malignant lymphomas of the nervous system. Acta Neuropathol. (Berl.) (Suppl. 6),69 -74.
This article has been cited by other articles:
![]() |
B. E. Figueroa, J. R. Brown, A. Nascimento, D. C. Fisher, and S. Tuli Unusual Sites of Hodgkin's Lymphoma: CASE 2. Hodgkin's Lymphoma of the CNS Masquerading As Meningioma J. Clin. Oncol., October 15, 2004; 22(20): 4228 - 4230. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|